Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment

The processes of cancer initiation, progression, and response to therapy are affected by the sex of cancer patients. Immunotherapy responses largely depend on the tumor microenvironment (TME), but how sex may shape some TME features, remains unknown. Here, we analyzed immune infiltration signatures...

Full description

Bibliographic Details
Main Authors: Junwei Han, Yang Yang, Xiangmei Li, Jiashuo Wu, Yuqi Sheng, Jiayue Qiu, Qian Wang, Ji Li, Yalan He, Liang Cheng, Yan Zhang
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.13203
_version_ 1828728989295837184
author Junwei Han
Yang Yang
Xiangmei Li
Jiashuo Wu
Yuqi Sheng
Jiayue Qiu
Qian Wang
Ji Li
Yalan He
Liang Cheng
Yan Zhang
author_facet Junwei Han
Yang Yang
Xiangmei Li
Jiashuo Wu
Yuqi Sheng
Jiayue Qiu
Qian Wang
Ji Li
Yalan He
Liang Cheng
Yan Zhang
author_sort Junwei Han
collection DOAJ
description The processes of cancer initiation, progression, and response to therapy are affected by the sex of cancer patients. Immunotherapy responses largely depend on the tumor microenvironment (TME), but how sex may shape some TME features, remains unknown. Here, we analyzed immune infiltration signatures across 19 cancer types from 1771 male and 1137 female patients in The Cancer Genome Atlas to evaluate how sex may affect the tumor mutational burden (TMB), immune scores, stromal scores, tumor purity, immune cells, immune checkpoint genes, and functional pathways in the TME. Pan‐cancer analyses showed higher TMB and tumor purity scores, as well as lower immune and stromal scores in male patients as compared to female patients. Lung adenocarcinoma, lung squamous carcinoma, kidney papillary carcinoma, and head and neck squamous carcinoma showed the most significant sex biases in terms of infiltrating immune cells, immune checkpoint gene expression, and functional pathways. We further focused on lung adenocarcinoma samples in order to identify and validate sex‐specific immune cell biomarkers with prognostic potential. Overall, sex may affect the tumor microenvironment, and sex‐specific TME biomarkers may help tailor cancer immunotherapy in certain cancer types.
first_indexed 2024-04-12T14:25:08Z
format Article
id doaj.art-58c543fa0e6f4c16910087baf97b8e14
institution Directory Open Access Journal
issn 1574-7891
1878-0261
language English
last_indexed 2024-04-12T14:25:08Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series Molecular Oncology
spelling doaj.art-58c543fa0e6f4c16910087baf97b8e142022-12-22T03:29:28ZengWileyMolecular Oncology1574-78911878-02612022-06-0116112153217310.1002/1878-0261.13203Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironmentJunwei Han0Yang Yang1Xiangmei Li2Jiashuo Wu3Yuqi Sheng4Jiayue Qiu5Qian Wang6Ji Li7Yalan He8Liang Cheng9Yan Zhang10College of Bioinformatics Science and Technology Harbin Medical University ChinaCollege of Bioinformatics Science and Technology Harbin Medical University ChinaCollege of Bioinformatics Science and Technology Harbin Medical University ChinaCollege of Bioinformatics Science and Technology Harbin Medical University ChinaCollege of Bioinformatics Science and Technology Harbin Medical University ChinaCollege of Bioinformatics Science and Technology Harbin Medical University ChinaCollege of Bioinformatics Science and Technology Harbin Medical University ChinaCollege of Bioinformatics Science and Technology Harbin Medical University ChinaCollege of Bioinformatics Science and Technology Harbin Medical University ChinaCollege of Bioinformatics Science and Technology Harbin Medical University ChinaSchool of Life Science and Technology Computational Biology Research Center Harbin Institute of Technology ChinaThe processes of cancer initiation, progression, and response to therapy are affected by the sex of cancer patients. Immunotherapy responses largely depend on the tumor microenvironment (TME), but how sex may shape some TME features, remains unknown. Here, we analyzed immune infiltration signatures across 19 cancer types from 1771 male and 1137 female patients in The Cancer Genome Atlas to evaluate how sex may affect the tumor mutational burden (TMB), immune scores, stromal scores, tumor purity, immune cells, immune checkpoint genes, and functional pathways in the TME. Pan‐cancer analyses showed higher TMB and tumor purity scores, as well as lower immune and stromal scores in male patients as compared to female patients. Lung adenocarcinoma, lung squamous carcinoma, kidney papillary carcinoma, and head and neck squamous carcinoma showed the most significant sex biases in terms of infiltrating immune cells, immune checkpoint gene expression, and functional pathways. We further focused on lung adenocarcinoma samples in order to identify and validate sex‐specific immune cell biomarkers with prognostic potential. Overall, sex may affect the tumor microenvironment, and sex‐specific TME biomarkers may help tailor cancer immunotherapy in certain cancer types.https://doi.org/10.1002/1878-0261.13203immune and stromal scoressex differencessex‐specific prognostic biomarkerstumor microenvironmenttumor mutational burden
spellingShingle Junwei Han
Yang Yang
Xiangmei Li
Jiashuo Wu
Yuqi Sheng
Jiayue Qiu
Qian Wang
Ji Li
Yalan He
Liang Cheng
Yan Zhang
Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment
Molecular Oncology
immune and stromal scores
sex differences
sex‐specific prognostic biomarkers
tumor microenvironment
tumor mutational burden
title Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment
title_full Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment
title_fullStr Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment
title_full_unstemmed Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment
title_short Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment
title_sort pan cancer analysis reveals sex specific signatures in the tumor microenvironment
topic immune and stromal scores
sex differences
sex‐specific prognostic biomarkers
tumor microenvironment
tumor mutational burden
url https://doi.org/10.1002/1878-0261.13203
work_keys_str_mv AT junweihan pancanceranalysisrevealssexspecificsignaturesinthetumormicroenvironment
AT yangyang pancanceranalysisrevealssexspecificsignaturesinthetumormicroenvironment
AT xiangmeili pancanceranalysisrevealssexspecificsignaturesinthetumormicroenvironment
AT jiashuowu pancanceranalysisrevealssexspecificsignaturesinthetumormicroenvironment
AT yuqisheng pancanceranalysisrevealssexspecificsignaturesinthetumormicroenvironment
AT jiayueqiu pancanceranalysisrevealssexspecificsignaturesinthetumormicroenvironment
AT qianwang pancanceranalysisrevealssexspecificsignaturesinthetumormicroenvironment
AT jili pancanceranalysisrevealssexspecificsignaturesinthetumormicroenvironment
AT yalanhe pancanceranalysisrevealssexspecificsignaturesinthetumormicroenvironment
AT liangcheng pancanceranalysisrevealssexspecificsignaturesinthetumormicroenvironment
AT yanzhang pancanceranalysisrevealssexspecificsignaturesinthetumormicroenvironment